Baxter issues update on IV solution shortages
Baxter Healthcare Corp. Friday updated U.S. hospital customers on its efforts to address a critical shortage of intravenous solutions since Hurricane Maria impacted its manufacturing facilities in Puerto Rico. Millions of units have been shipped to U.S. hospitals from Baxter facilities in other countries and all Baxter facilities on the island are now operating at pre-hurricane levels, the company said. While gaps in supply remain, in part due to high demand from a severe flu season, the company expects to return to more normal supply levels in coming weeks.
Related News Articles
Headline
A JAMA study published Aug. 20 found that nearly 63% of all U.S. drug production facilities from 2019 through 2024 were in counties where a weather disaster…
Headline
B. Braun Medical has voluntarily recalled two lots of Lactated Ringer’s Injection USP 1000 mL and 0.9% Sodium Chloride Injection USP 1000 mL IV fluids due to…
Headline
The White House Aug. 13 released an executive order directing the Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness…
Headline
The Food and Drug Administration has identified a Class I recall of Draeger SafeStar and TwinStar Filters due to a risk of misleading carbon dioxide readings.…
Headline
The Food and Drug Administration Aug. 8 announced an end to the national shortage of sodium chloride 0.9% IV solutions products. The agency said it continues…
Headline
The Food and Drug Administration Aug. 7 announced a new program to help improve the domestic pharmaceutical supply chain by increasing regulatory…